881386-12-5 (1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基,6-\u200b4-\u200b(5-\u200bBromo-\u200b1-\u200boxopentyl)\u200bamino\u200bphenyl\u200b-\u200b4,\u200b5,\u200b6,\u200b7-\u200btetrahydro-\u200b1-\u200b(4-\u200bmethoxyphenyl)\u200b-\u200b7-\u200boxo-1H-\u200bpyrazolo3,\u200b4-\u200bc\u200bpyridine-\u200b3-\u200bcarboxylic Acid\u200b Ethyl Ester)

CAS号:
881386-12-5
中文名称:
1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基
英文名称:
6-\u200b4-\u200b(5-\u200bBromo-\u200b1-\u200boxopentyl)\u200bamino\u200bphenyl\u200b-\u200b4,\u200b5,\u200b6,\u200b7-\u200btetrahydro-\u200b1-\u200b(4-\u200bmethoxyphenyl)\u200b-\u200b7-\u200boxo-1H-\u200bpyrazolo3,\u200b4-\u200bc\u200bpyridine-\u200b3-\u200bcarboxylic Acid\u200b Ethyl Ester
分子式:
C27H29BrN4O5
分子量:
569.446965932846
API:

1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基(881386-12-5)名称与标识符

名称

中文别名:
1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-OXOPENTYL)氨基]苯基]-4,5,6,7-四氢-1-(4-甲氧基)-7-氧代乙酯;1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基;阿哌沙班杂质146;
英文别名:
ethyl 6-(4-(5-bromopentanamido)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;ethyl 6-(4-(5-bromopentanamido)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazol...;ETHYL 6-(4-(5-BROMOPENTANAMIDO)PHENYL)-1-(4-METHOXYPHENYL)-7-OXO-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOX...;ethyl 6-[4-(5-bromopentanoylamino)phenyl]-1-(4-methoxyphenyl)-7-o xo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate;Apixaban Impurity 146;Apixaban Related Compound G [USP RS];6-?[4-?[(5-?Bromo-?1-?oxopentyl)?amino]?phenyl]?-?4,?5,?6,?7-?tetrahydro-?1-?(4-?methoxyphenyl)?-?7-?oxo-1H-?pyrazolo[3,?4-?c]?pyridine-?3-?carboxylic Acid? Ethyl Ester;ethyl 6-[4-(5-bromopentanoylamino)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate;Ethyl 6-[4-[(5-bromo-1-oxopentyl)amino]phenyl]-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;SCHEMBL15174803;Apixaban Related Compound G [USP IMPURITY];Apixaban Related Compound G;881386-12-5;NR729P2SS7;1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 6-[4-[(5-bromo-1-oxopentyl)amino]phenyl]-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-, ethyl ester;6-[4-[(5-Bromo-1-oxopentyl)amino]phenyl]-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester;DB-208839;

标识符

InChIKey:
OUHRTPGKRLEZKI-UHFFFAOYSA-N
Inchi:
1S/C27H29BrN4O5/c1-3-37-27(35)24-22-15-17-31(19-9-7-18(8-10-19)29-23(33)6-4-5-16-28)26(34)25(22)32(30-24)20-11-13-21(36-2)14-12-20/h7-14H,3-6,15-17H2,1-2H3,(H,29,33)
SMILES:
BrCCCCC(NC1C=CC(=CC=1)N1C(C2=C(C(C(=O)OCC)=NN2C2C=CC(=CC=2)OC)CC1)=O)=O

1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基(881386-12-5)物化性质

计算特性

  • 精确分子量 : 568.13213g/mol
  • 氢键供体数量 : 1
  • 氢键受体数量 : 9
  • 可旋转化学键数量 : 12
  • 同位素质量 : 568.13213g/mol
  • 重原子数量 : 37
  • 复杂度 : 785
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 4.4
  • 拓扑分子极性表面积 : 103Ų

1H-吡唑[3,4-C]吡啶-3-羧基酸,6-[4-[(5-溴-1-氧戊基)氨基]苯基(881386-12-5)推荐厂家 更多厂家(8)